AI Signal & Stock Analysis · Avoid ↓
As of Sep 28 2026, 6:09 PM, AkshayaAI's signal for UTHR is Avoid ↓; the stock is at $485.54 (+2.12% today); neutral (RSI 42); technical trend is down-trend; news sentiment is negative.
Data as of Sep 28 2026, 6:09 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $485.54 |
| Change today | +2.12% |
| RSI (14) | 41.72 |
| Relative volume | 1.08 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $20.8B |
| Forward P/E | 16.87 |
| 52-week high | -20.3% away |
| 52-week low | +18.7% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Negative |
| Sector | Healthcare-Pharma |
| Next earnings | 8/5/2026 8:30:00 AM |
As of Sep 28 2026, 6:09 PM, AkshayaAI assigns UTHR (United Therapeutics Corp) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
UTHR's RSI is neutral (RSI 42). A reading above 70 is typically considered overbought and below 30 oversold.
UTHR is trading about 20% below its 52-week high and 19% above its 52-week low as of Sep 28 2026, 6:09 PM.
UTHR's next earnings date is 8/5/2026 8:30:00 AM.
UTHR is classified under Healthcare-Pharma in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for UTHR — not personalised investment advice. Always do your own research.
JNJ · ABBV · MRK · NVS · AMGN · GILD
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:09 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.